Predictors of the Therapeutic Response to Intralesional Bivalent HPV Vaccine in Wart Immunotherapy

Predictors of the Therapeutic Response to Intralesional Bivalent HPV Vaccine in Wart Immunotherapy

Variable intralesional immunotherapies have recently been proposed as a means of achieving a successful eradication of recurrent and recalcitrant human papillomavirus (HPV)-induced cutaneous and anogenital warts. The bivalent HPV vaccine is one of the newly proposed immunotherapeutic agents. We inve...

Full description

Bibliographic Details
Main Authors: Noha M. Hammad, Ayman Marei, Gamal El-Didamony, Zeinb Mortada, Mona Elradi, Amira Hamed Mohamed Afifi, Heba M. Kadry
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Vaccines
Subjects:
anogenital warts
bivalent HPV vaccine
cutaneous warts
human papillomavirus
interferon-gamma
interleukin-4
Online Access:https://www.mdpi.com/2076-393X/9/11/1280

Internet

https://www.mdpi.com/2076-393X/9/11/1280

Similar Items